Reason for request
Inclusion on the list of products reimbursed by National Insurance and for hospital use in the extension of indication: "Symptomatic relief in the treatment of ankylosing spondylitis".
Clinical Benefit
| Substantial |
Le service médical rendu par ces spécialités est important dans l'extension d’indication : soulagement des symptômes dans le traitement de la spondylarthrite ankylosante.
|
Clinical Added Value
| no clinical added value |
Dans le traitement de la spondylarthrite ankylosante, CELEBREX® n'apporte pas d'amélioration du service médical rendu (V) par rapport aux autres AINS.
|
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
h6yspVgqNUQwbXfN
